Bladder cancer, Bowel (colorectal) cancer, Breast cancer, Colon cancer, Head and neck cancers, Kidney cancer, Lung cancer, Non small cell lung cancer (NSCLC), Oesophageal cancer, Ovarian cancer, Pancreatic cancer, Secondary cancers
Results
Phase 1
This trial looked at a drug called LY3143921 hydrate for people with advanced . Advanced cancer is cancer that has spread into surrounding tissues or elsewhere in the body.
It was for people whose treatment had stopped working or they had all the available to them.
This trial was supported by Cancer Research UK. People could join the trial between 2017 and 2021. The team reported the results in 2026.
Recruitment start: 4 May 2017
Recruitment end: 21 December 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Richard Wilson
Cancer Research UK - regulatory@cancer.org.uk
Eli Lilly and Company Limited
The research team would like to thank all the patients who took part in this trial. By doing this, you’ve helped the research team learn more about cancer and how to treat it.
This is Cancer Research UK trial number CRUKD/17/004.
There is more information about this trial on the ISRCTN website (ISRCTN84044406):
Last reviewed: 07 Apr 2026
CRUK internal database number: 14696
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
